CMXC insider filings
Cell MedX Corp. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-01-10. Screen CMXC transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CMXC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Cell MedX Corp.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-01-10 | 4 | Jeffs David — Chief Executive Officer, Director, 10% owner | Grant/award (A): 73,959,726 @ $0.01 · Purchase (P): 7,500,000 @ $0.01 · Purchase (P): 7,500,000 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | Vahabzadeh Amir — Director, 10% owner | Grant/award (A): 61,755,148 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | Yaretz Dwayne — Director | Grant/award (A): 1,214,285 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | daCosta Joao — Director | Grant/award (A): 531,687 @ $0.01 | EDGAR |
| 2024-01-09 | 4 | JEFFS RICHARD — 10% owner | Purchase (P): 14,372,285 @ $0.01 | EDGAR |
| 2022-04-08 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.15 | EDGAR |
| 2022-02-11 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 300 @ $0.18 | EDGAR |
| 2022-02-08 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 7,000 @ $0.15 · Sale (S): 300 @ $0.18 | EDGAR |
| 2022-01-07 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 7,500 @ $0.15 | EDGAR |
| 2022-01-03 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 5,000 @ $0.18 | EDGAR |
| 2021-12-21 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 5,000 @ $18.20 | EDGAR |
| 2021-12-17 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 4,654 @ $0.19 | EDGAR |
| 2021-11-29 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 20,000 @ $0.17 | EDGAR |
| 2021-09-14 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.20 | EDGAR |
| 2021-09-10 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.22 | EDGAR |
| 2021-08-04 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 6,500 @ $0.26 | EDGAR |
| 2021-08-02 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.26 | EDGAR |
| 2021-07-29 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.26 | EDGAR |
| 2021-07-26 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.24 · Sale (S): 351 @ $0.28 | EDGAR |
| 2021-07-06 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 9,000 @ $0.26 | EDGAR |
| 2021-06-28 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 8,000 @ $0.25 | EDGAR |
| 2021-06-25 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 8,000 @ $0.25 | EDGAR |
| 2021-06-17 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 5,000 @ $0.28 · Sale (S): 5,000 @ $0.29 | EDGAR |
| 2021-06-15 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 5,000 @ $0.24 | EDGAR |
| 2021-06-01 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 5,000 @ $0.28 | EDGAR |
| 2021-04-30 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 10,000 @ $0.27 · Sale (S): 10,000 @ $0.28 · Sale (S): 22,150 @ $0.28 | EDGAR |
| 2021-04-26 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 25,000 @ $0.26 · Sale (S): 10,000 @ $0.26 | EDGAR |
| 2021-04-21 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 22,562 @ $0.25 · Sale (S): 27,438 @ $0.25 · Sale (S): 22,562 @ $0.25 · Sale (S): 24,780 @ $0.27 | EDGAR |
| 2021-04-19 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 23,500 @ $0.22 | EDGAR |
| 2021-04-07 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 20,000 @ $0.23 | EDGAR |
| 2021-03-31 | 4 | HARGREAVES BRADLEY S — VP Technology & Operations, Director, 10% owner | Sale (S): 25,000 @ $0.22 | EDGAR |
| 2021-03-31 | 4 | HARGREAVES BRADLEY S — VP Technolgy & Operations, Director, 10% owner | Sale (S): 18,911 @ $0.27 | EDGAR |
| 2021-03-31 | 4 | HARGREAVES BRADLEY S — VP Technolgy & Operations, Director, 10% owner | Sale (S): 19,700 @ $0.30 | EDGAR |
| 2021-02-16 | 4 | HARGREAVES BRADLEY S — VP, Technology and Operations, Director, 10% owner | Gift (G): 300,000 @ $0 | EDGAR |
| 2020-09-01 | 4 | HARGREAVES BRADLEY S — VP, Technology and Operations, Director, 10% owner | Option exercise (M): 1,234,855 @ $0.05 · Option exercise (M): 1,234,855 (derivative) @ $0 | EDGAR |
| 2020-09-01 | 4 | ARNETT JEAN M — 10% owner | Option exercise (M): 1,250,000 @ $0.05 · Option exercise (M): 1,250,000 (derivative) @ $0 | EDGAR |
| 2020-09-01 | 4 | MCENULTY FRANK — President and CEO, Director | Purchase (P): 40,000 @ $0.25 · Purchase (P): 40,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Cell MedX Corp.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-08 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-05 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-04-04 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CMXC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs